Modest trial samples will be sufficient to detect treatment effect on cognitive decline

Takeaway 

  • This study provides valuable data to help plan randomised controlled trials (RCTs) looking to prevent or delay cognitive decline in people with Down Syndrome (DS).

Why this matters

    Development of RCTs to fully understand the course of dementia progression is essential for improved detection and monitoring of cognitive changes.